世茂股份(600823.SH):控股子公司擬申請不超110億元的最高綜合授信額度
格隆匯5月26日丨世茂股份(600823.SH)公佈,為配合公司深圳龍崗項目的開發與建設,滿足項目日常經營和持續管理對資金的需求,公司控股子公司深圳市世茂新里程實業有限公司(“深圳世茂新里程”)擬向金融機構申請金額不超過人民幣110億元(含)的最高綜合授信額度,並擬以其位於深圳市龍崗區的世茂深港國際中心綜合體項目的部分土地使用權抵押擔保(對應評估價值人民幣155.74億元),公司控股子公司福建世茂新里程投資發展有限公司擬將所持的深圳世茂新里程100%的股權(認繳出資額為人民幣100億元)質押給該金融機構,為上述綜合授信提供不超過人民幣110億元的質押擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.